Clinical and biochemical predictors affect the choice and the short-term outcomes of different thrombolytic agents in acute myocardial infarction


EL-MENYAR A. A. , ALTAMIMI O. M. , GOMAA M. M. , DABDOOB W., ABBAS A. A. , RAHMAN M. O. A. , et al.

CORONARY ARTERY DISEASE, cilt.17, ss.431-437, 2006 (SCI İndekslerine Giren Dergi)

Özet

Background The presence of plasminogen activator inhibitor-1, angiotensin-converting enzyme and others may play a role in unsuccessful recanalization after thrombolytic therapy.